Hepatitis C Disease Management: Diagnosis to Treatment Alerts in CHORUS™
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Epividian
- 入组人数
- 1,063
- 试验地点
- 1
- 主要终点
- Prescriptions for HCV treatment
研究概览
简要总结
The objective of this study is to evaluate whether sending alerts to healthcare providers and clinic staff to identify patients with untreated hepatitis C infection can increase the uptake of hepatitis C treatment. A period of time without alerts will be compared to a period of time with alerts.
详细描述
The hepatitis C virus (HCV) is one of the most common bloodborne pathogens in the United States. A large proportion of people with HCV infection progress to chronic HCV infection despite the availability of effective treatment; chronic infection can result in cirrhosis, end-stage liver disease, liver cancer, and liver-related death. HCV infection can be cured most of the time with treatment. The objective of this before and after study is to evaluate whether sending alerts to healthcare providers and clinic staff to identify patients with untreated hepatitis C infection can increase the uptake of HCV treatment. A period of time without alerts will be compared to a period of time with alerts. Healthcare providers and clinic staff will not receive alerts during the before period of the study. Healthcare providers and clinic staff will receive alerts during the after period of the study.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Other
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •18+ years of age
- •In care at an AIDS Healthcare Foundation Healthcare Center
- •Active, untreated HCV infection
排除标准
- •<18 years of age
- •Patients with active HCV infection who have a current prescription for HCV treatment
结局指标
主要结局
Prescriptions for HCV treatment
时间窗: End of follow-up, up to 9 months
Proportion of patients who are prescribed HCV treatment over follow-up, out of patients with a completed visit over follow-up.
次要结局
- HCV RNA viral load tests(End of follow-up, up to 9 months)
